Taken together, these independent studies indicate that CD47 blockade suppresses lung tumor growth by inducing phagocytic clearance of cancer cells by DCs and macrophages, which can engage adaptive immune responses to further inhibit tumor progression in immunocompetent hosts. Here, CD47 is linked to cancer.